Spec: Enrich top hypothesis h-61196ade — TREM2 evidence & gene expression
Task
Enrich the #1 ranked hypothesis (TREM2-Dependent Microglial Senescence Transition) with:
Additional PubMed evidence (for + against)
Proper dimension scores (were all 0.5 defaults)
Gene expression context from Allen Brain AtlasWork Log
2026-04-02 — Enrichment complete
- Evidence: Expanded from 10 for / 3 against to 16 for / 11 against via PubMed search
- Scores: Set all 10 dimension scores based on literature evidence:
- Mechanistic plausibility: 0.88 (DAM pathway well-characterized)
- Confidence: 0.82 (strong human + mouse data, GWAS support)
- Novelty: 0.78 (senescence angle novel, TREM2 in AD established)
- Feasibility: 0.72 (senolytics exist, BBB delivery challenging)
- Impact: 0.91 (could transform neurodegeneration understanding)
- Druggability: 0.65 (TREM2 agonists in development)
- Safety: 0.58 (systemic senolytic effects concern)
- Competitive landscape: 0.70 (senescence angle is distinct)
- Data availability: 0.85 (rich transcriptomic + biomarker data)
- Reproducibility: 0.75 (DAM replicated, some conflicting results)
- Gene expression: Added Allen Brain Atlas regional expression profile + single-cell context
- All pages verified loading (200 OK)
2026-04-13 — Verification & task close
- Verified h-61196ade in live DB: all 10 dimension scores set, evidence_for=24179 chars (16 entries), gene_expression_context=1700 chars
- Verified API: GET /api/hypotheses/h-61196ade returns enriched hypothesis with all scores and evidence
- Verified page: GET /hypothesis/h-61196ade returns HTTP 200
- Commit eeac537ef exists on auth/main but not origin/main (orphan branch issue) — data written directly to DB and is live
- Task substantively complete; data verified live on main system